- Research works
- 46 fractional, all time
- Citations
- 4k 86.4 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 14% world 28%
Not ranked overall: Supratek Pharma (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Supratek Pharma (Canada)?
By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Biomedical Applications, Drug Delivery, Tumor Targeting, Cancer Therapy, Nanocarriers, Gene Therapy and Antiretroviral Therapy.
- Resistance Mechanisms
- Peptide Synthesis
- Neoadjuvant Therapy
- Foldamers
- Asymmetric Synthesis
- Biomarkers
- Radioimmunotherapy
- Multidrug Resistance
- Living Radical Polymerization
- Nuclear Receptors
- Click Chemistry
- Genomic Profiling
- Clinical Trials
- HIV Infection
- RNA Interference
- Drug Resistance
- Antiretroviral Therapy
- Gene Therapy
- Tumor Targeting
- Biomedical Applications
- Nanoparticles
- Drug Delivery
- Cancer Therapy
- Nanocarriers
- Self-Assembly
- Targeted Therapy
- siRNA Delivery
- Integrase Inhibitors
- Drug Discovery
- Micelles
- Immunotherapy
- Block Copolymers
- ATP-dependent Transporters
- PET Imaging
- Radiopharmaceuticals
- Heterocycles
- Enzyme Regulation
- Medicinal Chemistry
- Nucleotide Metabolism
- Surgery
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Nanoparticles5▲ 8.9×4 topics
- Biomedical Applications5▲ 11×6 topics
- Drug Delivery5▲ 24×5 topics
- Tumor Targeting4▲ 64×2 topics
- Cancer Therapy4▲ 12×1 topic
- Gene Therapy4▲ 30×3 topics
- Nanocarriers4▲ 182×1 topic
- Antiretroviral Therapy3▲ 30×3 topics
- Self-Assembly3▲ 16×3 topics
- Drug Resistance3▲ 18×3 topics
- Targeted Therapy3▲ 26×3 topics
- RNA Interference2▲ 47×1 topic
- siRNA Delivery2▲ 69×1 topic
- HIV Infection2▲ 41×1 topic
- Integrase Inhibitors2▲ 123×1 topic
- Clinical Trials2▲ 7.2×3 topics
- Drug Discovery2▲ 11×4 topics
- Genomic Profiling2▲ 44×2 topics
- Micelles2▲ 54×2 topics
- Click Chemistry2▲ 52×2 topics
- Immunotherapy2▲ 6.3×7 topics
- Nuclear Receptors2▲ 23×2 topics
- Block Copolymers2▲ 76×1 topic
- Living Radical Polymerization2▲ 95×1 topic
- ATP-dependent Transporters2▲ 73×1 topic
- Multidrug Resistance2▲ 63×1 topic
- PET Imaging2▲ 17×2 topics
- Radioimmunotherapy2▲ 83×1 topic
- Radiopharmaceuticals2▲ 83×1 topic
- Biomarkers1▲ 5.0×3 topics
- Heterocycles1▲ 17×3 topics
- Asymmetric Synthesis1▲ 17×3 topics
- Enzyme Regulation1▲ 52×1 topic
- Foldamers1▲ 33×1 topic
- Medicinal Chemistry1▲ 7.2×4 topics
- Neoadjuvant Therapy1▲ 12×2 topics
- Nucleotide Metabolism1▲ 72×1 topic
- Peptide Synthesis1▲ 33×1 topic
- Surgery1▲ 8.3×2 topics
- Resistance Mechanisms1▲ 33×2 topics
Which research topics does Supratek Pharma (Canada) publish most on?
By volume in 2022–2025: Prostate Cancer Treatment and Research, Flavonoids in Medical Research, Asthma and respiratory diseases and Inhalation and Respiratory Drug Delivery.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
- 2 Flavonoids in Medical Research Pharmacology 0 works
- 3 Asthma and respiratory diseases Physiology 0 works
- 4 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
- 5 Clinical Nutrition and Gastroenterology Nutrition and Dietetics 0 works
- 6 Fatty Acid Research and Health Nutrition and Dietetics 0 works
- 7 Lipid metabolism and disorders Cardiology and Cardiovascular Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Supratek Pharma (Canada)'s research output changed?
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Dorval
- GLS Industries (Canada)
- Canadian Urological Association
- Apollo Microwaves (Canada)
- Advantech AMT (Canada)
- Sigma Energy Storage (Canada)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.